Cargando…
Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study
Glioblastoma (GBM) is a hypervascular and aggressive primary malignant tumor of the central nervous system. Recent investigations showed that traditional therapies along with antiangiogenic therapies failed due to the development of post-therapy resistance and recurrence. Previous investigations sho...
Autores principales: | Ali, Sehar, Borin, Thaiz F., Piranlioglu, Raziye, Ara, Roxan, Lebedyeva, Iryna, Angara, Kartik, Achyut, Bhagelu R., Arbab, Ali Syed, Rashid, Mohammad H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864405/ https://www.ncbi.nlm.nih.gov/pubmed/33544755 http://dx.doi.org/10.1371/journal.pone.0246646 |
Ejemplares similares
-
Critical immunosuppressive effect of MDSC-derived exosomes in the tumor microenvironment
por: Rashid, Mohammad H., et al.
Publicado: (2021) -
CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy–Resistant Glioblastoma
por: Angara, Kartik, et al.
Publicado: (2018) -
HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model
por: Borin, Thaiz F., et al.
Publicado: (2017) -
Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma
por: Arbab, Ali S., et al.
Publicado: (2017) -
Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis
por: Borin, Thaiz F., et al.
Publicado: (2017)